David Dickinson, DPM
Podiatrist · du Quoin, ILNPI 1346372687
Payments from drug & device makers
Across 46 payments — averaging $87.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$2K
- Arthrex$1K
- Mallinckrodt Hospital Products Inc.$140
- Paratek Pharmaceuticals, Inc.$129
- UCB, Inc.$59
- Organogenesis Inc.$48
- plus $430 from 17 others
What the payments were for
- Travel & lodging$74018%
- Food & beverage$88322%
- Education$2,40060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 6 | $1,720 |
| Arthrex | 3 | $1,496 |
| Mallinckrodt Hospital Products Inc. | 5 | $140 |
| Paratek Pharmaceuticals, Inc. | 2 | $129 |
| UCB, Inc. | 2 | $59 |
| Organogenesis Inc. | 3 | $48 |
| Smith+Nephew | 3 | $46 |
| Idorsia Pharmaceuticals US Inc | 3 | $42 |
| Bayer | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Zimmer Biomet | 2 | $33 |
| Amgen(2 entities) | 2 | $32 |
| AbbVie | 1 | $23 |
| Kerecis Limited | 1 | $23 |
| Rhythm Pharmaceuticals, Inc. | 1 | $21 |
| International Life Sciences | 1 | $20 |
| Advanced Oxygen Therapy Inc. | 1 | $20 |
| Treace Medical Concepts, Inc. | 1 | $20 |
| Mimedx Group, Inc. | 1 | $17 |
| EBI, LLC | 1 | $16 |
| Highridge Medical LLC | 1 | $16 |
| Reprise Biomedical, Inc. | 1 | $15 |
| KCI USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$115
How this compares
$4,022 in reported general payments places this provider in the 80th percentile of 409 podiatrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 59 | $1,769 |
| Terbinafine Hcl | 93 | $1,358 |
| Doxycycline Hyclate | 62 | $663 |
| Gabapentin | 39 | $465 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $162 |
| Levofloxacin | 21 | $142 |
| Cephalexin | 14 | $131 |
| Allopurinol | 16 | $102 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $73 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in du Quoin
- David YeagerMorrison$345K
- Syed HusainArlington Heights$248K
- Bela PanditEvergreen Park$164K
- Paul KirchnerNew Lenox$143K
- William BushRockford$141K
- Daniel BrownHarrisburg$136K
- Timothy GrahamTaylorville$70K
- Paul PotachWheeling$45K
- Steven JasonowiczBarrington$34K
- Jaclyn SchumannJoliet$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.